Mark Wade Moore
9Patents
2h-index
8Co-inventors
44Inventor score
Filing activity: Jun 27, 1995 → Apr 17, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5874080A | Anti-IL-8 monoclonal antibodies for treatment of asthma | Chemistry; Metallurgy | 21 | Expired |
| US7105484B2 | GDNF receptorα | Chemistry; Metallurgy | 3 | Expired |
| US9918997B2 | Compositions and methods for the treatment of neurodegenerative and other diseases | Human Necessities | 1 | Active |
| US7691606B2 | Polynucleotides encoding GDNFRα | Chemistry; Metallurgy | 1 | Active |
| US9980978B2 | Compositions and methods for the treatment of neurodegenerative and other diseases | Human Necessities | 0 | Active |
| US9974798B2 | Compositions and methods for the treatment of neurodegenerative and other diseases | Human Necessities | 0 | Active |
| US9597339B2 | Compositions and methods for the treatment of neurodegenerative and other diseases | Human Necessities | 0 | Active |
| US6504007B1 | GDNF receptor | Chemistry; Metallurgy | 0 | Expired |
| US10398713B2 | Compositions and methods for the treatment of neurodegenerative and other diseases | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.